Have a personal or library account? Click to login
Detection performance and prognostic value of initial bone marrow involvement in diffuse large B-cell lymphoma: a single centre 18F-FDG PET/CT and bone marrow biopsy evaluation study Cover

Detection performance and prognostic value of initial bone marrow involvement in diffuse large B-cell lymphoma: a single centre 18F-FDG PET/CT and bone marrow biopsy evaluation study

Radiology and Oncology
Volume 58 (2024): Issue 1 (March 2024)
By:
Open Access
|Feb 2024

References

  1. Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med 2021; 384: 842–58. doi: <a href="https://doi.org/10.1056/NEJMra2027612" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1056/NEJMra2027612</a>
    Open DOISearch in Google ScholarBack to article
  2. Cheson BD, Ansell S, Schwartz L, Gordon LI, Advani R, Jacene HA, et al. Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy. Blood 2016; 128: 2489–96. doi: <a href="https://doi.org/10.1182/blood-2016-05-718528" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1182/blood-2016-05-718528</a>
    Open DOISearch in Google ScholarBack to article
  3. Sehn LH, Scott DW, Chhanabhai M, Berry B, Ruskova A, Berkahn L, et al. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol 2011; 29: 1452–7. doi: <a href="https://doi.org/10.1200/JCO.2010.33.3419" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1200/JCO.2010.33.3419</a>
    Open DOISearch in Google ScholarBack to article
  4. Adams HJ, Nievelstein RA, Kwee TC. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma. Blood Rev 2015; 29: 417–25. doi: <a href="https://doi.org/10.1016/j.blre.2015.06.003" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.blre.2015.06.003</a>
    Open DOISearch in Google ScholarBack to article
  5. Khan AB, Barrington SF, Mikhaeel NG, Hunt AA, Cameron L, Morris T, et al. PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement. Blood 2013; 122: 61–7. doi: <a href="https://doi.org/10.1182/blood-2012-12-473389" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1182/blood-2012-12-473389</a>
    Open DOISearch in Google ScholarBack to article
  6. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014; 32: 3059–68. doi: <a href="https://doi.org/10.1200/JCO.2013.54.8800" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1200/JCO.2013.54.8800</a>
    Open DOISearch in Google ScholarBack to article
  7. Bain BJ. Bone marrow biopsy morbidity and mortality. Br J Haematol 2003; 121: 949–51. doi: <a href="https://doi.org/10.1046/j.1365-2141.2003.04329.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1365-2141.2003.04329.x</a>
    Open DOISearch in Google ScholarBack to article
  8. Basu S, Alavi A. SPECT-CT and PET-CT in oncology – an overview. Curr Med Imaging Rev 2011; 7: 202–9. doi: <a href="https://doi.org/10.2174/157340511796411168" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2174/157340511796411168</a>
    Open DOISearch in Google ScholarBack to article
  9. Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, et al. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. J Nucl Med 2013; 54: 1244–50. doi: <a href="https://doi.org/10.2967/jnumed.112.114710" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2967/jnumed.112.114710</a>
    Open DOISearch in Google ScholarBack to article
  10. El Karak F, Bou-Orm IR, Ghosn M, Kattan J, Farhat F, Ibrahim T, et al. PET/CT scanner and bone marrow biopsy in detection of bone marrow involvement in diffuse large B-cell lymphoma. PLoS One 2017; 12: e0170299. doi: <a href="https://doi.org/10.1371/journal.pone.0170299" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1371/journal.pone.0170299</a>
    Open DOISearch in Google ScholarBack to article
  11. Hao B, Zhao L, Luo NN, Ruan D, Pang YZ, Guo W, et al. Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using 18F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy. BMC Cancer 2018; 18: 1192. doi: <a href="https://doi.org/10.1186/s12885-018-5104-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/s12885-018-5104-0</a>
    Open DOISearch in Google ScholarBack to article
  12. Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 2015; 42: 328–54. doi: <a href="https://doi.org/10.1007/s00259-014-2961-x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s00259-014-2961-x</a>
    Open DOISearch in Google ScholarBack to article
  13. Lee SH, Erber WN, Porwit A, Tomonaga M, Peterson LC. International Council for Standardization in hematology. ICSH guidelines for the standardization of bone marrow specimens and reports. Int J Lab Hematol 2008; 30: 349–64. doi: <a href="https://doi.org/10.1111/j.1751-553X.2008.01100.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1751-553X.2008.01100.x</a>
    Open DOISearch in Google ScholarBack to article
  14. Brozic A, Pohar Marinsek Z, Novakovic S, Kloboves Prevodnik V. Inconclusive flow cytometric surface light chain results; can cytoplasmic light chains, Bcl-2 expression and PCR clonality analysis improve accuracy of cytological diagnoses in B-cell lymphomas? Diagn Pathol 2015; 10: 191. doi: <a href="https://doi.org/10.1186/s13000-015-0427-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/s13000-015-0427-5</a>
    Open DOISearch in Google ScholarBack to article
  15. Brožič A. [Clonality and antigenic properties of reactive and neoplastic lymphocytic proliferations]. [Slovenian]. [Doctoral dissertation]. Ljubljana: University of Ljubljana. [cited 2023 Jul 27]. Available at: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=84423
    Search in Google ScholarBack to article
  16. Salaun PY, Gastinne T, Bodet-Milin C, Campion L, Cambefort P, Moreau, et al. Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin’s lymphoma: a reflection of disease infiltration or just inflammation? Eur J Nucl Med Mol Imaging 2009; 36: 1813–21. doi: <a href="https://doi.org/10.1007/s00259-009-1183-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s00259-009-1183-0</a>
    Open DOISearch in Google ScholarBack to article
  17. Zwarthoed C, El-Galaly TC, Canepari M, Ouvrier MJ, Viotti J, Ettaiche M, et al. Prognostic value of bone marrow tracer uptake pattern in baseline PET scans in Hodgkin lymphoma: results from an International Collaborative Study. J Nucl Med 2017; 58: 1249–54. doi: <a href="https://doi.org/10.2967/jnumed.116.184218" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2967/jnumed.116.184218</a>
    Open DOISearch in Google ScholarBack to article
  18. Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, et al. ESMO Guidelines Committee. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26: v116–25. doi: <a href="https://doi.org/10.1093/annonc/mdv304" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/annonc/mdv304</a>
    Open DOISearch in Google ScholarBack to article
  19. Wang J, Weiss LM, Chang KL, Slovak ML, Gaal K, Forman SJ, et al. Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer 2002; 94: 1522–31. doi: <a href="https://doi.org/10.1002/cncr.10364" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/cncr.10364</a>
    Open DOISearch in Google ScholarBack to article
  20. Salem P, Wolverson MK, Reimers HJ, Kudva GC. Complications of bone marrow biopsy. Br J Haematol 2003; 121: 821. doi: <a href="https://doi.org/10.1046/j.1365-2141.2003.04328.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1365-2141.2003.04328.x</a>
    Open DOISearch in Google ScholarBack to article
  21. Vieira L, Pires A, Grilo A. Anxiety experienced by oncological patients who undergo 18F-FDG PET CT: a systematic review. Radiography 2021; 27: 1203–10. doi: <a href="https://doi.org/10.1016/j.radi.2021.06.001" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.radi.2021.06.001</a>
    Open DOISearch in Google ScholarBack to article
  22. Elamir Y, Elazab M, Owis AS, Elsayed HF. PET/CT and bone marrow biopsy (BMB) in evaluating bone marrow in lymphoma. Egypt J Radiol Nucl Med 2020; 51: 201. doi: <a href="https://doi.org/10.1186/s43055-020-00318-8" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/s43055-020-00318-8</a>
    Open DOISearch in Google ScholarBack to article
  23. Büyükşimşek M, Kolsuz İ, Yetişir AE, Tohumcuoğlu M, Oğul A, Mirili C, et al. Performance of positron emission tomography-computed tomography and bone marrow biopsy in detecting bone marrow infiltration in lymphoma cases. Turk J Haematol 2020; 37: 220–25. doi: <a href="https://doi.org/10.4274/tjh.galenos.2020.2019.0361" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.4274/tjh.galenos.2020.2019.0361</a>
    Open DOISearch in Google ScholarBack to article
  24. Pelosi E, Penna D, Douroukas A, Bellò M, Amati A, Arena V, et al. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study. Q J Nucl Med Mol Imaging 2011; 55: 469–75. PMID: 21150862
    Search in Google ScholarBack to article
  25. Kandeel AA, Hussein M, Zidan L, Younis J, Edesa W, Alsayed Y. Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. Nucl Med Commun 2020; 41: 269–79. doi: <a href="https://doi.org/10.1097/MNM.0000000000001139" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/MNM.0000000000001139</a>
    Open DOISearch in Google ScholarBack to article
  26. Almaimani J, Tsoumpas C, Feltbower R, Polycarpou I. FDG PET/CT versus bone marrow biopsy for diagnosis of bone marrow involvement in non-hodgkin lymphoma: a systematic review. Applied Sciences 2022; 12: 540. doi: <a href="https://doi.org/10.3390/app12020540" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3390/app12020540</a>
    Open DOISearch in Google ScholarBack to article
  27. Chang JM, Lee HJ, Goo JM, Lee HY, Lee JJ, Chung JK, et al. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol 2006; 7: 57–69. doi: <a href="https://doi.org/10.3348/kjr.2006.7.1.57" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3348/kjr.2006.7.1.57</a>
    Open DOISearch in Google ScholarBack to article
  28. Aoki J, Watanabe H, Shinozaki T, Takagishi K, Ishijima H, Oya N, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001; 219: 774–7.
    Search in Google ScholarBack to article
  29. Yao Z, Deng L, Xu-Monette ZY, Manyam GC, Jain P, Tzankov A, et al. Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy. Leukemia 2018; 32: 353–63. doi: <a href="https://doi.org/10.1038/leu.2017.222." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/leu.2017.222.</a>
    Open DOISearch in Google ScholarBack to article
  30. Alonso-Álvarez S, Alcoceba M, García-Álvarez M, Blanco O, Rodríguez M, Baile M, et al. Biological features and prognostic impact of bone marrow infiltration in patients with diffuse large b-cell lymphoma. Cancers 2020; 12: 474. doi: <a href="https://doi.org/10.3390/cancers12020474" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3390/cancers12020474</a>
    Open DOISearch in Google ScholarBack to article
  31. Horvat M, Zadnik V, Južnič Šetina T, Boltežar L, Pahole Goličnik J, Novaković S, et al. Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone. Oncol Lett 2018; 15: 3602–9. doi: <a href="https://doi.org/10.3892/ol.2018.7774" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3892/ol.2018.7774</a>
    Open DOISearch in Google ScholarBack to article
DOI: https://doi.org/10.2478/raon-2024-0004 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 15 - 22
Submitted on: Oct 15, 2023
Accepted on: Jan 3, 2024
Published on: Feb 21, 2024
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
F-FDG PET/CT,
Diffuse Large B-Cell Lymphoma,
bone marrow,
biopsy,
overall survival
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2024 Andrej Doma, Katarina Zevnik, Andrej Studen, Veronika Kloboves Prevodnik, Gorana Gasljevic, Barbara Jezersek Novakovic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 58 (2024): Issue 1 (March 2024)Next article